期刊文献+

氨基末端B型利钠肽前体联合血红蛋白对充血性心力衰竭患者病情的评估价值 被引量:12

Clinical Value of Combined Detection of NT-proBNP and Hemoglobin in Patients with Congestive Heart Failture
下载PDF
导出
摘要 目的评价氨基末端B型利钠肽前体(NT-proBNP)联合血红蛋白(Hb)测定对充血性心力衰竭(CHF)患者病情的评估价值。方法测定107例CHF住院患者入院时的NT-proBNP、Hb水平等指标,对患者进行心功能分级,观察其住院期间心脏不良事件的发生情况。结果贫血患者的NT-proBNP、Hb水平与无贫血患者比较,差异有统计学意义(P<0.05);NYHA分级不同,患者的NT-proBNP、Hb水平比较,差异有统计学意义(P<0.01)。贫血且NT-proBNP≥中位数的患者,中重度心力衰竭发生率(100.0%)及住院期间心脏不良事件发生率(52.9%)显著高于单独贫血患者(70.6%和23.7%)及NT-proBNP≥中位数患者(70.9%和20.0%),差异有统计学意义(P<0.05)。结论联合检测NT-proBNP及Hb可以更全面地评估CHF患者的病情和预测住院期间心脏不良事件的发生。 Objective To evaluate the value of combined detection of N-Terminal ptro-brain natriuretic peptide(NT-proBNP)and hemoglobin(Hb) in patients with congestive heart failture.Methods The level of plasma NT-proBNP and Hb of 107 patients with congestive heart failture was measured when they were admitted.The NYHA heart function was assessed and the incidence of adverse cardic events was observed during the period of in-hospital.Results The level of NT-proBNP and Hb in patients with anemia had statistical difference compared with that in patients without anemia(P0.05).Patients with different NYHA had statistical difference in NT-proBNP and Hb levels(P0.05).The incidence of moderate and severe heart failure of patients with anemia and NT-proBNP levels above the median were 100.0%,while the incidence rate of adverse cardic events were 52.9%,both higher than those of patients with anemia or NT-proBNP levels below the median alone(P0.05).Conclusion The combined detection of NT-proBNP and hemoglobin can assess more comprehensively the cardiac functional grading and major adverse cardiac events of patient with congestive heart failure during the period of in-hospital.
作者 向凝
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第5期500-502,共3页 Chinese General Practice
关键词 氨基末端B型利钠肽前体 血红蛋白 心力衰竭 预后 NT-proBNP Hemoglobin Congestive heart failure Prognosis
  • 相关文献

参考文献14

  • 1戴维靖,姚渭清.血清N末端脑利钠肽前体与肌钙蛋白对婴幼儿充血性心力衰竭的诊断价值研究[J].实用心脑肺血管病杂志,2010,18(12):1750-1752. 被引量:4
  • 2Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failture and is associated with poor outcomes: insights from a coeort of 12065 patients with new - onset heart failture [ J]. Circulution, 2003: 107:223-225.
  • 3Philipp S, Ollmann H, Schink T, et al. The impact of anaemia and kidney function in congestive heart failure and preserved systolic function [J]. NephrolDialTransplaot, 2005, 20 (5): 915-919.
  • 4O'Meara E, Clayton T, McEntegart MB, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure resluts of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program [J]. Circulation, 2006, 114 (7): 986-994.
  • 5Silverberg DS, Wexler D, Blum M, et al. Erythropoietin should be a part of congestive heart failure management [J]. Kidney Int, 2003, 64 (Suppl) : 40 - 47.
  • 6Ishani A, Weinhandl E, Zhao Z, et al. Angiotension - converting enzyme inhibitor as a risk factor for the development of anemia and the impact of incident anemia on mortality in patients with left ventricular dys- function [J]. J Am Coil Cardiol, 2005, 45 (3) : 391 -399.
  • 7Anand IS, Kuskowski MA, Rector TS, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val - HeFT [ J ]. Circulation, 2005, 112 (8): 1121-1127.
  • 8Krack A, Sharma R, Figulla HR, et al. The importance of the gastrointestinal system in the pathogenesis of heart faihure [J]. Eur Heart J, 2005, 26 (22): 2368-2374.
  • 9Androne AS, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure [J]. Circulation, 2003, 107 (2) : 226 - 229.
  • 10Kalra PR, Anagnostopoulos C, Bolger AP, et al. The regulation and measurement of plasma volume in heart failure [J]. J Am Coll Cardiol, 2002, 39: 1902-1908.

二级参考文献5

共引文献3

同被引文献81

引证文献12

二级引证文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部